Company profile

Cullgen (Shanghai),Inc

Privately held: no public share price (Acquired by Gyre Therapeutics in an all-stock deal that closed 4 May 2026; now a wholly-owned subsidiary with no independent equity. (CT.gov codes this sponsor OTHER, but it is a commercial company — excluded from the noncommercial set on that basis.) Parent: Gyre Therapeutics, Inc. (Nasdaq: GYRE). [resolved 2026-08-05 by resolve-null-is-public; source: https://www.biospace.com/press-releases/gyre-therapeutics-completes-acquisition-of-cullgen-to-create-u-s-and-china-based-fully-integrated-biopharmaceutical-company]) · United States / China